Likewise, treatment with ATRA promotes a striking up-regulation of adhesion molecules on APL blast cells such as CD11b, CD11c, CD15, CD65, and CD54, thus leading to lung infiltration and inflammation [41,42,43]. The gene discussed is ICAM1; the disease is acute promyelocytic leukemia.